What public sources say about the safety of creatine: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.
Interactions and safety, in NIH's words
Studies have found no consistent set of side effects from creatine use, except that it often leads to weight gain, because it increases water retention and possibly stimulates muscle protein synthesis [112,113]. Several studies have found that supplemental creatine monohydrate, when used for a strength-training program, can lead to a 1–2 kg increase in total body weight in a month [73].
Creatine is considered safe for short-term use by healthy adults [12,112,113,114]. In addition, evidence shows that use of the product for several years is safe [112,120-122]. Anecdotal reactions to creatine use include nausea, diarrhea and related gastrointestinal distress, muscle cramps, and heat intolerance. Creatine supplementation may reduce the range of motion of various parts of the body (such as the shoulders, ankles, and lower legs) and lead to muscle stiffness and resistance to stretching [114]. Adequate hydration while taking creatine might minimize these uncommon risks [113].
Quoted from the “Creatine (safety)” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.
FDA adverse-event reports (CAERS)
Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “CREATINE”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.
Combination products: 10 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 164 reports where a product is named for creatine alone. This split is made from product names and can misfile some products. Most-reported products: Creatine (13); Muscletech Essential Series Platinum 100% Creatine Powder (7); Creatine Monohydrate (7); Pro Performance Amp Amplified Creatine 189 (6); Gnc Creatine Monohydrate (5); Rsp Creatine Monohydrate (4).
| Most reported reactions (single-ingredient products) | Reports |
|---|---|
| Nausea | 22 |
| Vomiting | 16 |
| Dyspnoea | 13 |
| Headache | 13 |
| Dizziness | 13 |
| Abdominal pain | 10 |
| Fatigue | 10 |
| Heart rate increased | 10 |
| Chromaturia | 10 |
| Blood creatine phosphokinase increased | 9 |
| Chest pain | 9 |
| Rhabdomyolysis | 9 |
Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (93), Hospitalization (58), Visited Emergency Room (43), Visited a Health Care Provider (36), Other Serious Outcome (14), Required Intervention (12), Life Threatening (11), Death (9).
Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.
Registered trials
49 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.
- Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) Completed Results posted
- Creatine Safety & Tolerability in Huntington's Disease Completed Results posted
- A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder Completed Results posted
- Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram Completed Results posted
- Creatine Use and Muscle Stretching in Peripheral Artery Disease Completed Results posted
- Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis Completed
- Creatine for the Treatment of Amyotrophic Lateral Sclerosis Completed
- Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] Completed
- Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression Completed
- Effectiveness of Creatine on Pain, Fatigue, and Muscle Architectural Variables in Patients Witg Fibromyalgia. Completed
- Effects of Creatine Supplementation in Women With Knee Osteoarthritis and Fibromyalgia Completed
- Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability Completed
- Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study Completed
- Creatine Therapy for Huntington's Disease Completed
- Effect of Creatine Supplementation and Exercise on Bone Health Completed
- Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone Completed
- Creatine Supplementation and Bone Mass Completed
- National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial Completed
- Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients Completed
- CLUSTER TRAINING + CREATINE PROJECT Completed